Current Report Filing (8-k)
March 03 2023 - 8:31AM
Edgar (US Regulatory)
0001326706
false
0001326706
2023-02-28
2023-02-28
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): February 28, 2023
NanoVibronix,
Inc.
(Exact
name of registrant as specified in its charter)
Delaware |
|
001-36445 |
|
01-0801232 |
(State
or other jurisdiction
of
incorporation) |
|
(Commission
File
Number) |
|
(IRS
Employer
Identification
No.) |
525
Executive Blvd
Elmsford,
New York |
|
10523 |
(Address
of principal executive offices) |
|
(Zip
Code) |
Registrant’s
telephone number, including area code: (914) 233-3004
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol |
|
Name
of each exchange on which registered |
Common
Stock, par value $0.001 per share |
|
NAOV |
|
Nasdaq
Capital Market |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
As
previously reported, on October 17, 2022, NanoVibronix, Inc. (the “Company”), was granted an extension by the Nasdaq Hearings
Panel (the “Panel”), through February 23, 2023, to regain compliance with the $1.00 bid price requirement for continued listing
on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2).
On
February 28, 2023, the Panel confirmed the Company’s compliance with all applicable criteria for continued listing on The Nasdaq
Capital Market, including compliance with Nasdaq Listing Rule 5550(a)(2). Accordingly, the previously announced listing matter has been
closed.
On
March 3, 2023, the Company issued a press release announcing its compliance with Nasdaq Listing Rule 5550(a)(2). A copy of the press
release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is hereby incorporated by reference herein.
Item 9.01 |
Financial Statements and Exhibits. |
(d)
Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
|
NanoVibronix,
Inc. |
|
|
|
Date:
March 3, 2023 |
By: |
/s/
Stephen Brown |
|
Name: |
Stephen
Brown |
|
Title: |
Chief
Financial Officer |
NanoVibronix (NASDAQ:NAOV)
Historical Stock Chart
From Jul 2024 to Aug 2024
NanoVibronix (NASDAQ:NAOV)
Historical Stock Chart
From Aug 2023 to Aug 2024